Predict your next investment

MediSix Therapeutics company logo
HEALTHCARE | Biotechnology
medisixtx.com

See what CB Insights has to offer

Founded Year

2016

Stage

Series B | Alive

Total Raised

$40.36M

Last Raised

$20.36M | 2 yrs ago

About MediSix Therapeutics

MediSix Therapeutics is a Singapore-based immune engineering company developing cellular therapies to address T cell malignancies.

MediSix Therapeutics Headquarter Location

11 Biopolis Way #05-08/09 Helios

138667,

Singapore

Latest MediSix Therapeutics News

MediSix launches with $20M series A

May 21, 2018

MediSix launches with $20M series A 7:13 AM PDF Cell therapy company MediSix Therapeutics Pte. Ltd. (Singapore) launched with a $20 million series A round led by... Read the full 69 word article User Sign in Individual Use $30.00 USD What is BioCentury? BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MediSix Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MediSix Therapeutics is included in 4 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

R

Regenerative Medicine

1,708 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

C

Cancer

4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

MediSix Therapeutics Patents

MediSix Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/9/2018

Immune system, Clusters of differentiation, Immunology, Olfactory receptors, Transcription factors

Application

Application Date

8/9/2018

Grant Date

Title

Related Topics

Immune system, Clusters of differentiation, Immunology, Olfactory receptors, Transcription factors

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.